Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexosome Immunotherapy in Stage IV Melanoma
NCT00042497Phase 2Suspended
- Sponsor
- Anosys, Inc.
- Start
- Jul 2002
- Modality
- Lipid-based Nanoparticles
01
Overview
A Phase 2 trial of autologous dexosomes loaded with tumor-specific peptides in melanoma, sponsored by Anosys, Inc.. Started Jul 2002; status: suspended.
02
Drugs
autologous dexosomes loaded with tumor-specific peptides
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00042497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042497.